Evidence map›Paper›PMID 41392654›Full record

ArticleBJOG : an international journal of obstetrics and gynaecology2026

Quality of Medication Abortion Services From Pharmacies and Drugstores in Ethiopia: A Two-Stage Study.

Tesfaye Tufa, Stephanie Andrea Küng, Delayehu Bekele, Niguse Tadele, Mahari Yihdego, Kidist Lemma, Alice F Cartwright

Abstract read
In one paragraph

Article in BJOG : an international journal of obstetrics and gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tesfaye TufaUniversity of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-8623-9113
Stephanie Andrea KüngGuttmacher Institute, New York City, New York, USA.
Delayehu BekeleSt. Paul Institute for Reproductive Health and Rights, Addis Ababa, Ethiopia.
Niguse TadeleAddis Ababa University, Addis Ababa, Ethiopia.
Mahari YihdegoPerformance Monitoring for Action Ethiopia, Addis Ababa, Ethiopia.
Kidist LemmaSt. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Alice F CartwrightGuttmacher Institute, New York City, New York, USA.

Funding

Government of Canada
6 · The paper itself

Abstract

objectiveTo assess the quality of medication abortion (MA) services provided in pharmacies and drugstores ('pharmaceutical outlets') in Ethiopia.

designA two-stage cross-sectional study.

settingPharmaceutical outlets in Addis Ababa, Ethiopia. SAMPLE: Phase 1: 1696 pharmaceutical outlets listed in the Ethiopian Federal Ministry of Health Master Facility Registry, plus 187 additional outlets identified in the field. Phase 2: Selected 600 pharmaceutical outlets.

methodsAfter assessing stock availability in phase 1, during phase 2, mystery clients (MCs) visited pharmaceutical outlets to evaluate service quality using an adapted version of the Abortion Care Quality (ACQ) Tool. Descriptive statistics were used to characterise the quality of services provided by the outlets.

main outcome measuresThe quality of abortion services provided by pharmaceutical outlets.

resultsAbortion medications were sold without prescriptions in 23.5% of MC visits. Among these sales, client respect (95.7%) and confidentiality (84.4%) were high. Additionally, 67.1% of staff gave correct instructions on dosage, timing, and administration of the medications. However, less than half of the MCs received adequate information on possible complications (36.4%). Almost all medications purchased were unexpired, packaged in aluminum, and of a known brand (96.5%); however, none were characterised as affordable.

conclusionsPharmaceutical outlets demonstrated moderate quality for MA services, yet there were notable gaps in counselling for physical side effects and complications, and affordability challenges. With appropriate policy adjustments and training interventions, there is potential to integrate pharmaceutical outlets into the abortion care service delivery infrastructure, ensuring equitable access to safe and effective abortion services in Ethiopia.

Indexed as

Abortifacient AgentsPharmaceutical ServicesPharmaciesReproductive Health ServicesAbortion, InducedCross-Sectional StudiesEthiopiaHealth Services AccessibilityAbortifacient Agentsabortion caredrugstoremedication abortionmystery clientpharmacies

Identifiers

PMID41392654
PMCPMC12884203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.